ASTH Stock: Price, Earnings History and SEC Filings
Astrana Health, Inc. (ASTH) last traded at $36.53, down 0.25% on the latest session and up 2.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.40 against an analyst estimate of $0.31, a beat of 29.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ASTH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.40 | $0.31 | +29.03% |
| Mar 2026 | May 7, 2026 | $0.74 | $0.29 | +155.17% |
| Dec 2025 | Mar 2, 2026 | $0.54 | $0.15 | +260.00% |
| Sep 2025 | Nov 6, 2025 | $0.01 | $0.47 | -97.87% |
ASTH beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How ASTH reacts to earnings
Across its last 8 earnings releases, ASTH moved 17.1% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | +4.78% |
| 2026-05-07 | After close | +8.92% |
| 2026-03-02 | Before open | +29.46% |
| 2025-11-06 | After close | -23.44% |
| 2025-08-07 | After close | +30.85% |
| 2025-07-02 | Before open | -1.64% |
| 2025-05-08 | After close | -11.15% |
| 2025-02-27 | After close | -26.82% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ASTH financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $3.2B | $22M | $104M | 0.7% | $0.46 |
| 2024 | $2.0B | $43M | $44M | 2.1% | $0.90 |
| 2023 | $1.4B | $61M | $40M | 4.4% | $1.29 |
| 2022 | $1.1B | $45M | $59M | 3.9% | $0.99 |
| 2021 | $774M | $69M | $51M | 8.9% | $1.52 |
| 2020 | $687M | $38M | $45M | 5.5% | $1.01 |
| 2019 | $561M | $14M | $13M | 2.5% | $0.39 |
| 2018 | $520M | $11M | $24M | 2.1% | $0.29 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ASTH
- 8-K · Sep 23, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Sep 23, 2026
- 8-K · Sep 15, 2026Regulation FD disclosure, Financial statements and exhibits
- 10-Q · Aug 10, 2026
- 8-K · Aug 6, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jul 13, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jul 1, 2026Officer or director change
- 8-K · Jun 10, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 8-K · May 12, 2026Officer or director change
- 8-K · May 12, 2026Regulation FD disclosure, Financial statements and exhibits
Insider filing activity
ASTH insiders filed 10 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ASTH news
- What’s Behind Alignment Healthcare (ALHC) Stock’s Latest Move?Oct 31, 2026 · finance.yahoo.com
- How Investors May Respond To Alignment Healthcare (ALHC) New Medicare PlanOct 19, 2026 · finance.yahoo.com
- Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California SeniorsOct 19, 2026 · finance.yahoo.com
About Astrana Health, Inc.
Astrana Health, Inc. (ASTH) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-management Consulting Services. It is incorporated in DE. Its fiscal year ends in December.